Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, et al
Discussing these pre-existing conditions with your provider is crucial, as alternative options may be more suitable
During the study, the study d A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before Intervention 1 Intervention 2 Not provided Anticipated Start Date Not provided Actual Start Date 2019-05-09 Anticipated Date of Last Follow-up 2021-03-05 Estimated Primary Completion Date Not provided Estimated Completion Date Not provided Actual Primary Completion Date 2019-12-12 Actual Completion Date 2020-01-17 Age Cohort Genders Accepts pregnant individuals Unspecified Accepts lactating individuals Unspecified Accepts healthy individuals No Inclusion Criteria: * Male or female, aged 18-75 years (both inclusive) at the time of signing informed consent * Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days prior to the day of screening * HbA1c of 7.0-10.0% (53.0-85.8 mmol/mol) (both inclusive) as assessed by central laboratory * Stable daily dose(s) for 90 days prior to the day of screening of any of the following antidiabetic drug(s) or combination regime(s): 1
Research frequently focuses on how GLP-1 activity may influence hunger management and calorie intake
MTHFR itself is not linked to reduced life expectancy, but the health risks associated with elevated homocysteinesuch as heart disease and strokecan affect longevity if left unmanaged
Mechanism of Action Cellular Structure Support : L-Carnosine helps support healthy cellular structures, promoting the cellular components that maintain DNA integrity during normal cell division
